$11.99
Live
2.56%
Downside
Day's Volatility :5.61%
Upside
3.13%
64.97%
Downside
52 Weeks Volatility :69.37%
Upside
12.55%
Period | Lifevantage Corp | Index (Russel 2000) |
---|---|---|
3 Months | 88.87% | 0.0% |
6 Months | 101.98% | 0.0% |
1 Year | 68.55% | 0.0% |
3 Years | 78.92% | -23.0% |
Market Capitalization | 150.9M |
Book Value | $2.08 |
Dividend Share | 0.145 |
Dividend Yield | 1.35% |
Earnings Per Share (EPS) | 0.23 |
PE Ratio | 52.57 |
PEG Ratio | 0.0 |
Wall Street Target Price | 7.0 |
Profit Margin | 1.47% |
Operating Margin TTM | 5.95% |
Return On Assets TTM | 4.28% |
Return On Equity TTM | 9.69% |
Revenue TTM | 200.2M |
Revenue Per Share TTM | 16.07 |
Quarterly Revenue Growth YOY | -9.8% |
Gross Profit TTM | 170.0M |
EBITDA | 7.9M |
Diluted Eps TTM | 0.23 |
Quarterly Earnings Growth YOY | -0.31 |
EPS Estimate Current Year | 0.65 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Downside of 41.62%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 226.0M | ↑ 11.2% |
Net Income | 7.4M | ↑ 28.95% |
Net Profit Margin | 3.29% | ↑ 0.45% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 232.9M | ↑ 3.08% |
Net Income | 11.5M | ↑ 55.46% |
Net Profit Margin | 4.96% | ↑ 1.67% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 220.2M | ↓ 5.47% |
Net Income | 12.9M | ↑ 11.65% |
Net Profit Margin | 5.86% | ↑ 0.9% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 206.4M | ↓ 6.28% |
Net Income | 3.1M | ↓ 75.8% |
Net Profit Margin | 1.51% | ↓ 4.35% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 213.4M | ↑ 3.41% |
Net Income | 2.5M | ↓ 18.59% |
Net Profit Margin | 1.19% | ↓ 0.32% |
FY24 | Y/Y Change | |
---|---|---|
Revenue | 200.2M | ↓ 6.2% |
Net Income | 2.9M | ↑ 15.63% |
Net Profit Margin | 1.47% | ↑ 0.28% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 53.7M | ↑ 0.15% |
Net Income | 1.0M | ↓ 196.6% |
Net Profit Margin | 1.9% | ↑ 3.87% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 54.2M | ↑ 0.89% |
Net Income | 2.0M | ↑ 92.37% |
Net Profit Margin | 3.63% | ↑ 1.73% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 51.4M | ↓ 5.27% |
Net Income | 629.0K | ↓ 68.01% |
Net Profit Margin | 1.22% | ↓ 2.41% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 51.6M | ↑ 0.51% |
Net Income | -656.0K | ↓ 204.29% |
Net Profit Margin | -1.27% | ↓ 2.49% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 48.2M | ↓ 6.55% |
Net Income | 1.7M | ↓ 352.9% |
Net Profit Margin | 3.44% | ↑ 4.71% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 48.9M | ↑ 1.42% |
Net Income | 1.3M | ↓ 21.34% |
Net Profit Margin | 2.67% | ↓ 0.77% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 55.3M | ↑ 8.08% |
Total Liabilities | 28.1M | ↓ 3.84% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 58.9M | ↑ 6.52% |
Total Liabilities | 25.6M | ↓ 8.73% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 78.7M | ↑ 33.72% |
Total Liabilities | 41.9M | ↑ 63.62% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 70.7M | ↓ 10.19% |
Total Liabilities | 39.2M | ↓ 6.52% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 66.1M | ↓ 6.48% |
Total Liabilities | 31.5M | ↓ 19.69% |
FY24 | Y/Y Change | |
---|---|---|
Total Assets | 60.3M | ↓ 8.81% |
Total Liabilities | 34.3M | ↑ 9.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 67.1M | ↓ 1.11% |
Total Liabilities | 33.6M | ↓ 6.39% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 66.1M | ↓ 1.43% |
Total Liabilities | 31.5M | ↓ 6.44% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 66.6M | ↑ 0.73% |
Total Liabilities | 37.3M | ↑ 18.54% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 62.7M | ↓ 5.89% |
Total Liabilities | 35.4M | ↓ 5.19% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 61.3M | ↓ 2.19% |
Total Liabilities | 34.5M | ↓ 2.37% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 60.3M | ↓ 1.64% |
Total Liabilities | 34.3M | ↓ 0.67% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 17.8M | ↑ 34.2% |
Investing Cash Flow | -4.5M | ↓ 3.08% |
Financing Cash Flow | -11.1M | ↑ 217.83% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 18.3M | ↑ 3.02% |
Investing Cash Flow | -2.7M | ↓ 40.5% |
Financing Cash Flow | -12.4M | ↑ 11.7% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 16.3M | ↓ 11.2% |
Investing Cash Flow | -3.7M | ↑ 39.28% |
Financing Cash Flow | -11.5M | ↓ 7.8% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 8.0M | ↓ 51.09% |
Investing Cash Flow | -1.5M | ↓ 59.03% |
Financing Cash Flow | -9.0M | ↓ 21.84% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 6.8M | ↓ 14.21% |
Investing Cash Flow | -3.1M | ↑ 99.93% |
Financing Cash Flow | -2.4M | ↓ 73.67% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 3.4M | ↑ 256.05% |
Investing Cash Flow | -505.0K | ↓ 39.67% |
Financing Cash Flow | -306.0K | ↓ 23.5% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 3.8M | ↑ 9.29% |
Investing Cash Flow | -505.0K | ↑ 0.0% |
Financing Cash Flow | -1.3M | ↑ 332.35% |
Sell
Neutral
Buy
Lifevantage Corp is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Lifevantage Corp | 16.71% | 101.98% | 68.55% | 78.92% | -17.26% |
Kraft Heinz Company, The | 3.81% | -5.64% | 15.68% | -1.04% | 29.45% |
Mccormick & Company, Incorporated | -3.62% | 7.35% | 31.79% | -0.16% | -1.24% |
Hormel Foods Corporation | 2.26% | -8.39% | 3.97% | -22.73% | -20.79% |
General Mills, Inc. | -5.74% | -1.74% | 10.6% | 11.91% | 33.17% |
Kellanova | 0.53% | 39.79% | 64.17% | 31.4% | 29.68% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Lifevantage Corp | 52.57 | 52.57 | 0.0 | 0.65 | 0.1 | 0.04 | 0.01 | 2.08 |
Kraft Heinz Company, The | 23.04 | 23.04 | 0.93 | 3.02 | 0.04 | 0.04 | 0.04 | 40.44 |
Mccormick & Company, Incorporated | 27.27 | 27.27 | 2.64 | 2.93 | 0.15 | 0.05 | 0.02 | 20.2 |
Hormel Foods Corporation | 22.51 | 22.51 | 2.66 | 1.58 | 0.1 | 0.05 | 0.04 | 14.35 |
General Mills, Inc. | 16.65 | 16.65 | 3.62 | 4.5 | 0.24 | 0.07 | 0.03 | 16.69 |
Kellanova | 32.28 | 32.28 | 1.64 | 3.7 | 0.23 | 0.06 | 0.03 | 9.66 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Lifevantage Corp | Buy | $150.9M | -17.26% | 52.57 | 1.47% |
Kraft Heinz Company, The | Buy | $43.6B | 29.45% | 23.04 | 7.3% |
Mccormick & Company, Incorporated | Hold | $21.5B | -1.24% | 27.27 | 11.87% |
Hormel Foods Corporation | Hold | $17.7B | -20.79% | 22.51 | 6.52% |
General Mills, Inc. | Hold | $38.8B | 33.17% | 16.65 | 12.14% |
Kellanova | Hold | $27.9B | 29.68% | 32.28 | 7.07% |
Insights on Lifevantage Corp
Revenue is up for the last 2 quarters, 48.24M → 48.93M (in $), with an average increase of 1.4% per quarter
Netprofit is down for the last 2 quarters, 1.65M → 1.30M (in $), with an average decrease of 21.3% per quarter
Renaissance Technologies Corp
Vanguard Group Inc
Dimensional Fund Advisors, Inc.
BlackRock Inc
Geode Capital Management, LLC
Bridgeway Capital Management, LLC
lifevantage is at the forefront of nutrigenomics, a new form of nutritional science that uses nutrients to create improved health and wellness. aging is inevitable. and we’re all painfully aware of the toll it takes on our bodies. nutrigenomics is serious science. and it’s graduated from the laboratory to real-life, creating a platform for products that really work – really.
Organization | Lifevantage Corp |
Employees | 222 |
CEO | Mr. Steven R. Fife |
Industry | Health Technology |
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$11.99
-1.88%
Invesco Bulletshares 2025 Hi
$11.99
-1.88%
Schwab International Dividend Equity Etf
$11.99
-1.88%
Blockchain Coinvestors Acquisition Corp.
$11.99
-1.88%
Allgiant Travel Company
$11.99
-1.88%
Rogers Corp
$11.99
-1.88%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$11.99
-1.88%
Iheartmedia
$11.99
-1.88%
Lightpath Technologies Inc
$11.99
-1.88%